JPRN-UMIN000023999已完成未知
The randomized controlled trial on the efficacy of mobile-app delivered cognitive behavioral therapy for insomnia - Mobile-app delivered cognitive behavioral therapy for insomnia
europsychiatric Research Institute0 个研究点目标入组 40 人开始时间: 2016年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Unable to use smartphone circadian rhythm disorder sleep apnea syndrome Restless legs syndrome hypersomnia
研究者
相似试验
已完成
不适用
The randomized controlled trial on the efficacy of cognitive behavior therapy for insomniaJPRN-UMIN000014297Department of Psychophysiology, National Institute of Mental Health, National Center of Neurology & Psychiatry60
已完成
3 期
The randomized controlled trial of the efficacy of goshajinkigan, mecobalamin and lafutidine in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000010969Department of breast and endocrine surgery, Meiwa Hospital50
已完成
3 期
The randomized controlled trial of the efficacy of goshajinkigan and lafutidine after mecobalamin administered in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000010988Department of breast and endocrine surgery, Meiwa Hospital35
已完成
3 期
The randomized controlled trial of the efficacy of mecobalamin and lafutidine after goshajinkigan administered in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000011007Department of breast and endocrine surgery, Meiwa Hospital35
尚未招募
1 期
A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19)ITMCTR2000003033Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine,